News – Page 330 – Endpoints News

ProKidney to establish cell therapy manufacturing site in North Carolina

3 years ago

Kura plans to sell $100M of shares on the back of interim readout of acute myeloid leukemia drug

3 years ago

Small private biotechs raise money in mostly early-stage financing

3 years ago

Axsome reports delay to PhIII narcolepsy study, unveils peak sales estimates on its drugs

3 years ago

Biogen lines up potential deal for ALS drug, doubling down on neurofilament biomarker

3 years ago

Patient death leads Seattle Children’s to pause study of 2seventy bio’s CAR-T cell therapy

3 years ago

Turnstone Biologics turns to public investors to fund TIL therapies in IPO filing

3 years ago

Bristol Myers offers a $100,000 vote of support for Kristen Hege's adventurous fundraising campaign

3 years ago

Encoded Therapeutics, a well-funded CNS gene therapy maker, lays off 10% of staff

3 years ago

Merck steps into NASH space with early data for its GLP-1/glucagon receptor co-agonist

3 years ago

$1 Daraprim? ImprimisRx facility in New Jersey hit with FDA warning letter

3 years ago

Bernie Sanders thinks the federal government needs a better ROI on its drug R&D

3 years ago

Gavi reports 'rebound' year for childhood vaccinations

3 years ago

Astellas loses patent infringement case over blockbuster bladder drug

3 years ago

AstraZeneca amps environmental goals with deal for renewable fuel use at all US sites

3 years ago

FDA ad watchdog sends first reprimand of 2023 to Xeris over ‘misleading’ drug claims

3 years ago

Lady Gaga takes center stage in Pfizer's Nurtec migraine campaign

3 years ago

Sarissa goes after Alkermes, seeking three board seats at the Irish drugmaker

3 years ago

Seagen touts PhII data for Adcetris/Opdivo combo; A-Alpha partners with Gilead on HIV

3 years ago

What to expect from this year's Cannes Lions pharma and health awards

3 years ago

Alladapt touts data on food allergy drug as it preps for PhIII

3 years ago

Erytech blasts activist investor's attempt to block reverse merger, Akkadian proposes new board in return

3 years ago

With promising PhII blood disorder data in hand, Disc Medicine seeks $100M in public offering

3 years ago

Exclusive: Battle with ‘undruggable’ cancer target beta-catenin heats up, as Sapience doses first patient

3 years ago

First page Previous page 327 328 329330331 332 333 Next page Last page